Anti-VEGFR Monoclonal Antibody

Any monoclonal antibody directed against the human tyrosine kinase vascular endothelial growth factor receptor (VEGFR), with potential anti… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2018
01220012018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Angiogenesis is a proven clinical target for the treatment of advanced epithelial ovarian cancer. Vascular endothelial growth… (More)
Is this relevant?
2018
2018
  • Marye J. Boers-Sonderena, Sasja F. Muldera, +6 authors Carla M. L. van Herpena
  • 2018
Background Diarrhea is a frequently occurring adverse event during treatment with vascular endothelial growth factor receptor… (More)
  • table I
  • table II
Is this relevant?
Review
2016
Review
2016
BACKGROUND We performed a systematic review and meta-analysis to determine the efficacy and safety of the US Food and Drug… (More)
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2015
2015
Background:Bone metastases (BMs) are associated with poor outcome in metastatic clear-cell renal carcinoma (m-ccRCC) treated with… (More)
Is this relevant?
Review
2014
Review
2014
Angiogenesis and immunosuppression work hand-in-hand in the renal cell carcinoma (RCC) microenvironment. Tumor growth is… (More)
  • figure 1
  • figure 2
Is this relevant?
2013
2013
352 Background: Compared with placebo, everolimus provided significant improvement in median PFS in the RECORD-1 study of VEGFr… (More)
Is this relevant?
2001
2001
Vascular endothelial growth factor (VEGF)-related factors are believed to regulate angiogenesis, an essential event in the growth… (More)
Is this relevant?